Literature DB >> 15298355

Lack of association between metabolic traits and the -512 polymorphism in FOXC2 in german people with normal glucose tolerance.

A Fritsche, F Machicao, H Staiger, H U Häring, M Stumvoll.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15298355     DOI： 10.1007/s00125-004-1364-0

Source DB:  PubMed          Journal:  Diabetologia        ISSN： 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  6 in total

1.  Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.

Authors:  M Stumvoll; A Mitrakou; W Pimenta; T Jenssen; H Yki-Järvinen; T Van Haeften; W Renn; J Gerich
Journal:  Diabetes Care       Date:  2000-03       Impact factor: 19.112

2.  FOXC2 mRNA Expression and a 5' untranslated region polymorphism of the gene are associated with insulin resistance.

Authors:  Martin Ridderstråle; Emma Carlsson; Mia Klannemark; Anna Cederberg; Christina Kösters; Hans Tornqvist; Heidi Storgaard; Allan Vaag; Sven Enerbäck; Leif Groop
Journal:  Diabetes       Date:  2002-12       Impact factor: 9.461

3.  FOXC2 is a winged helix gene that counteracts obesity, hypertriglyceridemia, and diet-induced insulin resistance.

Authors:  A Cederberg; L M Grønning; B Ahrén; K Taskén; P Carlsson; S Enerbäck
Journal:  Cell       Date:  2001-09-07       Impact factor: 41.582

4.  Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp.

Authors:  M Matsuda; R A DeFronzo
Journal:  Diabetes Care       Date:  1999-09       Impact factor: 19.112

5.  Genetic variation in the human winged helix/forkhead transcription factor gene FOXC2 in Pima Indians.

Authors:  Peter Kovacs; Angela Lehn-Stefan; Michael Stumvoll; Clifton Bogardus; Leslie J Baier
Journal:  Diabetes       Date:  2003-05       Impact factor: 9.461

6.  The FOXC2 -512C>T variant is associated with hypertriglyceridaemia and increased serum C-peptide in Danish Caucasian glucose-tolerant subjects.

Authors:  K Yanagisawa; L Hingstrup Larsen; G Andersen; T Drivsholm; A Cederberg; R Westergren; K Borch-Johnsen; O Pedersen; S Enerbäck; T Hansen
Journal:  Diabetologia       Date:  2003-10-07       Impact factor: 10.122
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.